![DEF 14A 1 a2207874zdef14a.htm DEF 14A QuickLinks -- Click here to rapidly navigate through this document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section ... DEF 14A 1 a2207874zdef14a.htm DEF 14A QuickLinks -- Click here to rapidly navigate through this document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section ...](https://www.sec.gov/Archives/edgar/data/1023131/000104746912003295/g15062bci002.gif)
DEF 14A 1 a2207874zdef14a.htm DEF 14A QuickLinks -- Click here to rapidly navigate through this document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section ...
![Covance starting to rebound, but clinical trial business still being hit by COVID-19 | Fierce Biotech Covance starting to rebound, but clinical trial business still being hit by COVID-19 | Fierce Biotech](https://qtxasset.com/quartz/qcloud5/media/image/fiercebiotech/1603802575/CovanceEvansville_3.jpg/CovanceEvansville_3.jpg?VersionId=ys40sTg3ReHX6gYsZ1IYZwPtUCZAVwJR)
Covance starting to rebound, but clinical trial business still being hit by COVID-19 | Fierce Biotech
![An Overview of Covance CRO Clinical Research I Covance Clinical Trials — Clinical Research Certification An Overview of Covance CRO Clinical Research I Covance Clinical Trials — Clinical Research Certification](https://images.squarespace-cdn.com/content/v1/56a042fb25981d9326c9bbdb/1595859656245-785LQPKHKHAOXLP2LZ9A/image-asset.jpeg?format=2500w)